Literature DB >> 11922748

Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

Hiroshi Yamazaki1, Mami Nakamura, Tomoko Komatsu, Katsuhiro Ohyama, Naoya Hatanaka, Satoru Asahi, Noriaki Shimada, F Peter Guengerich, Tsutomu Shimada, Miki Nakajima, Tsuyoshi Yokoi.   

Abstract

Drug oxidation activities of 12 recombinant human cytochrome P450s (P450) coexpressed with human NADPH-P450 reductase (NPR) in bacterial membranes (P450/NPR membranes) were determined and compared with those of other recombinant systems and those of human liver microsomes. Addition of exogenous membrane-bound NPR to the P450/NPR membranes enhanced the catalytic activities of CYP2C8, CYP2C9, CYP2C19, CYP3A4, and CYP3A5. Enhancement of activities of CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2D6, and CYP2E1 in membranes was not observed after the addition of NPR (4 molar excess to each P450). Exogenous purified human cytochrome b5 (b5) further enhanced catalytic activities of CYP2A6, CYP2B6, CYP2C8, CYP2E1, CYP3A4, and CYP3A5/NPR membranes. Catalytic activities of CYP2C9 and CYP2C19 were enhanced by addition of b5 in reconstituted systems but not in the P450/NPR membranes. Apo b5 (devoid of heme) enhanced catalytic activities when added to both membrane and reconstituted systems, except for CYP2E1/NPR membranes and the reconstituted system containing purified CYP2E1 and NPR. Catalytic activities in P450/NPR membranes fortified with b5 were roughly similar to those measured with microsomes of insect cells coexpressing P450 with NPR (and b5) and/or human liver microsomes, based on equivalent P450 contents. These results suggest that interactions of P450 and NPR coexpressed in membranes or mixed in reconstituted systems appear to be different in some human CYP2 family enzymes, possibly due to a conformational role of b5. P450/NPR membrane systems containing b5 are useful models for prediction of the rates for liver microsomal P450-dependent drug oxidations. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922748     DOI: 10.1006/prep.2001.1578

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  61 in total

1.  Human liver microsomal cytochrome P450 3A enzymes involved in thalidomide 5-hydroxylation and formation of a glutathione conjugate.

Authors:  Goutam Chowdhury; Norie Murayama; Yusuke Okada; Yasuhiro Uno; Makiko Shimizu; Norio Shibata; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

2.  Specificity determinants of CYP1B1 estradiol hydroxylation.

Authors:  Clinton R Nishida; Steven Everett; Paul R Ortiz de Montellano
Journal:  Mol Pharmacol       Date:  2013-07-02       Impact factor: 4.436

3.  Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes.

Authors:  Tsutomu Shimada; Shigeo Takenaka; Norie Murayama; Hiroshi Yamazaki; Joo-Hwan Kim; Donghak Kim; Francis K Yoshimoto; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2015-02-16       Impact factor: 3.739

4.  Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5.

Authors:  Robert D Finn; Lesley A McLaughlin; Sebastien Ronseaux; Ian Rosewell; J Brian Houston; Colin J Henderson; C Roland Wolf
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

5.  A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.

Authors:  Xiaochao Ma; Connie Cheung; Kristopher W Krausz; Yatrik M Shah; Ting Wang; Jeffrey R Idle; Frank J Gonzalez
Journal:  Drug Metab Dispos       Date:  2008-09-17       Impact factor: 3.922

6.  Mammalian cytochrome P450 enzymes catalyze the phenol-coupling step in endogenous morphine biosynthesis.

Authors:  Nadja Grobe; Baichen Zhang; Ursula Fisinger; Toni M Kutchan; Meinhart H Zenk; F Peter Guengerich
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

7.  Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.

Authors:  Prachi Bajpai; Michelle C Sangar; Shilpee Singh; Weigang Tang; Seema Bansal; Goutam Chowdhury; Qian Cheng; Ji-Kang Fang; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

8.  Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.

Authors:  Patrick R Porubsky; Kathleen M Meneely; Emily E Scott
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2',5'-Tetrachlorobiphenyl.

Authors:  Tsutomu Shimada; Kensaku Kakimoto; Shigeo Takenaka; Nobuyuki Koga; Shotaro Uehara; Norie Murayama; Hiroshi Yamazaki; Donghak Kim; F Peter Guengerich; Masayuki Komori
Journal:  Drug Metab Dispos       Date:  2016-09-13       Impact factor: 3.922

10.  Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling.

Authors:  Hiroshi Yamazaki; Kana Horiuchi; Ryohji Takano; Taku Nagano; Makiko Shimizu; Masato Kitajima; Norie Murayama; Fumiaki Shono
Journal:  Int J Environ Res Public Health       Date:  2010-09-01       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.